Cladis Investment Advisory, LLC Eli Lilly & CO Transaction History
Cladis Investment Advisory, LLC
- $114 Million
- Q1 2024
A detailed history of Cladis Investment Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cladis Investment Advisory, LLC holds 5,144 shares of LLY stock, worth $4.06 Million. This represents 3.52% of its overall portfolio holdings.
Number of Shares
5,144
Previous 6,161
16.51%
Holding current value
$4.06 Million
Previous $3.59 Million
11.42%
% of portfolio
3.52%
Previous 3.34%
Shares
6 transactions
Others Institutions Holding LLY
# of Institutions
3,775Shares Held
736MCall Options Held
7.09MPut Options Held
7.23M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$76.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$57.5 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$51.6 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$40.6 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$27.1 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $751B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...